Last update:

Continuing tirzepatide at full dose helps preserve weight loss over 112 weeks

New research presented at the European Congress on Obesity (ECO 2026) in Istanbul, Turkey (12–15 May) and published in The Lancet shows that people who have lost weight using the maximum tolerated dose (MTD) of tirzepatide ...

Most weight loss achieved using injectable obesity drugs can be maintained by switching to orforglipron, study shows

New research presented at the European Congress on Obesity (ECO2026) in Istanbul, Turkey (12–15 May) and published in Nature Medicine shows that most weight loss achieved using the injectable obesity drugs tirzepatide or ...

Medical research news

Pediatric surgery program cuts opioid use by 56%

A 21-element recovery program for children undergoing gastrointestinal surgery reduced opioid use during hospitalization by 56%, according to a large clinical trial led by Northwestern University and Ann & Robert H. Lurie ...

No refrigeration needed for next-gen malaria vaccine

Malaria is a deadly disease killing more than half a million people every year, but a new vaccine is showing promise as it not only offers long-lasting strong protection but also inhibits transmission of malaria by mosquitoes. ...